435 related articles for article (PubMed ID: 19275709)
61. Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors: Implementation of apoptotic genes expression for ulcerogenic liability assessment.
Marzouk AA; Taher ES; Shaykoon MSA; Lan P; Abd-Allah WH; Aboregela AM; El-Behairy MF
Bioorg Chem; 2021 Jun; 111():104883. PubMed ID: 33865053
[TBL] [Abstract][Full Text] [Related]
62. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
Abdelgawad MA; Labib MB; Abdel-Latif M
Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
[TBL] [Abstract][Full Text] [Related]
63. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM
Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
[TBL] [Abstract][Full Text] [Related]
64. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
Firke SD; Bari SB
Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
[TBL] [Abstract][Full Text] [Related]
65. Synthesis, Cyclooxygenase-2 Inhibition, Anti-inflammatory Evaluation and Docking Study of Substituted-N-(3,4,5-trimethoxyphenyl)-benzo[d]oxazole Derivatives.
Kaur A; Wakode S; Pathak DP; Sharma V; Shakya AK
Med Chem; 2018; 14(7):660-673. PubMed ID: 29564981
[TBL] [Abstract][Full Text] [Related]
66. A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug.
Mohy El-Din MM; Senbel AM; Bistawroos AA; El-Mallah A; Nour El-Din NA; Bekhit AA; Abd El Razik HA
Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):263-73. PubMed ID: 21138530
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives.
Domiati S; El-Mallah A; Ghoneim A; Bekhit A; El Razik HA
Inflammopharmacology; 2016 Aug; 24(4):163-72. PubMed ID: 27342269
[TBL] [Abstract][Full Text] [Related]
68. New pyrazole derivatives possessing amino/methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies.
Abdellatif KRA; Abdelall EKA; Lamie PF; Labib MB; El-Nahaas ES; Abdelhakeem MM
Bioorg Chem; 2020 Jan; 95():103540. PubMed ID: 31911297
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and biological evaluation of 4-arylphthalazones bearing benzenesulfonamide as anti-inflammatory and anti-cancer agents.
Yaseen S; Ovais S; Bashir R; Rathore P; Samim M; Singh S; Nair V; Javed K
Arch Pharm (Weinheim); 2013 Jun; 346(6):491-8. PubMed ID: 23670888
[TBL] [Abstract][Full Text] [Related]
70. Synthesis and evaluation of pyrazolines bearing benzothiazole as anti-inflammatory agents.
Kharbanda C; Alam MS; Hamid H; Javed K; Bano S; Dhulap A; Ali Y; Nazreen S; Haider S
Bioorg Med Chem; 2014 Nov; 22(21):5804-12. PubMed ID: 25311566
[TBL] [Abstract][Full Text] [Related]
71. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors.
Gedawy EM; Kassab AE; El Kerdawy AM
Eur J Med Chem; 2020 Mar; 189():112066. PubMed ID: 31982653
[TBL] [Abstract][Full Text] [Related]
72. New
Szczukowski Ł; Krzyżak E; Wiatrak B; Jawień P; Marciniak A; Kotynia A; Świątek P
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681894
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA
Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994
[TBL] [Abstract][Full Text] [Related]
74. New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES.
Hassan GS; Abdel Rahman DE; Abdelmajeed EA; Refaey RH; Alaraby Salem M; Nissan YM
Eur J Med Chem; 2019 Jun; 171():332-342. PubMed ID: 30928706
[TBL] [Abstract][Full Text] [Related]
75. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
76. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents.
Bano S; Javed K; Ahmad S; Rathish IG; Singh S; Alam MS
Eur J Med Chem; 2011 Dec; 46(12):5763-8. PubMed ID: 22019186
[TBL] [Abstract][Full Text] [Related]
78. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
[TBL] [Abstract][Full Text] [Related]
79. Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II.
El-Feky SA; Abd El-Samii ZK; Osman NA; Lashine J; Kamel MA; Thabet HKh
Bioorg Chem; 2015 Feb; 58():104-16. PubMed ID: 25590381
[TBL] [Abstract][Full Text] [Related]
80. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents.
Hassan GS; Abou-Seri SM; Kamel G; Ali MM
Eur J Med Chem; 2014 Apr; 76():482-93. PubMed ID: 24607877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
